OS Cancer Research Results
OS, overall survival: Click to Expand ⟱
| Source: |
| Type: |
Overall survival
|
Stroke, Cerebral Ischemic Stroke: Click to Expand ⟱
Ischemic stroke is also called brain ischemia and cerebral ischemia. Ischemia is the medical term for "lack of blood supply."
|
Scientific Papers found: Click to Expand⟱
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*neuroP↑, *Inflam↓, *antiOx↑, *cardioP↑, *NRF2↑, *AMPK↑, *SOD↑, *Catalase↑, *GSH↑, *GPx↑, *ROS↓, *TNF-α↓, *IL6↓, *NF-kB↓, *COX2↓, *glucose↓, *TRPC1↓, *Ca+2↓, *HO-1↑, *NF-kB↓, *PPARα↝, *Hif1a↓, *JNK↓, *BP↓, *AntiDiabetic↑, *hepatoP↑, *TLR4↓, *NRF2↑, *Casp↓, *neuroP↑, *Aβ↓, *LDH↓, *MDA↓, *memory↑, *AChE↓, *eff↑, EMT↝, N-cadherin↓, E-cadherin↑, TumCCA↑, ROS↑, p‑P53↑, HO-1↑, NRF2↑, ChemoSen↑, mtDam↑, Casp3↑, Casp9↑, PARP↑, Bax:Bcl2↑, TumCG↓, cycD1/CCND1↓, cMyc↓, CDK2↓, mitResp↓, Glycolysis↓, Hif1a↓, PCNA↓, p‑GSK‐3β↓, VEGF↓, PI3K↓, Akt↓, mTOR↓, OS↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*cognitive↑, AntiCan↑, *Inflam↓, *antiOx↑, *ROS↓, *neuroP↑, *SOD↑, *GPx↑, *MDA↑, *BBB↑, *OS↑, *Ca+2↓, *APP↓, *p‑tau↓,
| - |
in-vivo, |
ALS, |
NA |
|
|
|
- |
NA, |
Stroke, |
NA |
|
|
|
- |
NA, |
AD, |
NA |
|
|
|
- |
NA, |
Park, |
NA |
|
|
|
*eff↑, *ROS↓, *GSH↑, *NRF2↑, *motorD↑, *OS↑, *neuroP↑, *BBB↑, *cognitive↑, *eff↑, *antiOx↑, *Cyt‑c↑, *PGC-1α↑,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
NA, |
AD, |
NA |
|
|
|
- |
NA, |
Diabetic, |
NA |
|
|
|
- |
NA, |
Stroke, |
NA |
|
|
|
- |
NA, |
LiverDam, |
NA |
|
|
|
- |
NA, |
Park, |
NA |
|
|
|
*mtDam↓, *BioAv↝, *BioAv↑, *OS↑, *eff↑, *eff↑, *cognitive↑, *DNAdam↓, *SIRT1↑, *cardioP↑, *ROS↓, *Dose↝, *BioAv↑, *hepatoP↑, *eff↑, *BG↓, *creat↓,
*OS↑, *antiOx↑, Sp1/3/4↓,
*OS↑, *BDNF↑, *IGF-1↑,
| - |
in-vitro, |
Stroke, |
NA |
|
|
|
- |
in-vivo, |
Nor, |
NA |
|
|
|
*eff↑, *OS↑, *Inflam↓, *ROS↓, *NRF2↑, *HO-1↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
ostP, |
NA |
|
|
|
- |
Review, |
IBD, |
NA |
|
|
|
*MitoP↓, *Strength↑, *PINK1↑, *PARK2↑, *Inflam↓, *COX2↓, *IL1β↓, *IL6↓, *TNF-α↓, *OS↑, *cardioP↑, *memory↑, *neuroG↑, *neuroP↑, *Cartilage↑, *Inflam↓, *RenoP↑, *eff↑, *Dose↝, *Half-Life↑, *NRF2↑, *GutMicro↑,
Showing Research Papers: 1 to 8 of 8
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 8
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
HO-1↑, 1, NRF2↑, 1, ROS↑, 1,
Mitochondria & Bioenergetics ⓘ
mitResp↓, 1, mtDam↑, 1,
Core Metabolism/Glycolysis ⓘ
cMyc↓, 1, Glycolysis↓, 1,
Cell Death ⓘ
Akt↓, 1, Bax:Bcl2↑, 1, Casp3↑, 1, Casp9↑, 1,
Kinase & Signal Transduction ⓘ
Sp1/3/4↓, 1,
DNA Damage & Repair ⓘ
p‑P53↑, 1, PARP↑, 1, PCNA↓, 1,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, cycD1/CCND1↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
EMT↝, 1, p‑GSK‐3β↓, 1, mTOR↓, 1, PI3K↓, 1, TumCG↓, 1,
Migration ⓘ
E-cadherin↑, 1, N-cadherin↓, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 1, VEGF↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, OS↑, 1,
Total Targets: 30
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 4, Catalase↑, 1, GPx↑, 2, GSH↑, 2, HO-1↑, 2, MDA↓, 1, MDA↑, 1, NRF2↑, 5, PARK2↑, 1, ROS↓, 5, SOD↑, 2,
Mitochondria & Bioenergetics ⓘ
mtDam↓, 1, PGC-1α↑, 1, PINK1↑, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, glucose↓, 1, LDH↓, 1, PPARα↝, 1, SIRT1↑, 1,
Cell Death ⓘ
Casp↓, 1, Cyt‑c↑, 1, JNK↓, 1,
Autophagy & Lysosomes ⓘ
MitoP↓, 1,
DNA Damage & Repair ⓘ
DNAdam↓, 1,
Proliferation, Differentiation & Cell State ⓘ
IGF-1↑, 1, neuroG↑, 1,
Migration ⓘ
APP↓, 1, Ca+2↓, 2, Cartilage↑, 1, TRPC1↓, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 1,
Barriers & Transport ⓘ
BBB↑, 2,
Immune & Inflammatory Signaling ⓘ
COX2↓, 2, IL1β↓, 1, IL6↓, 2, Inflam↓, 5, NF-kB↓, 2, TLR4↓, 1, TNF-α↓, 2,
Synaptic & Neurotransmission ⓘ
AChE↓, 1, BDNF↑, 1, p‑tau↓, 1,
Protein Aggregation ⓘ
Aβ↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↑, 2, BioAv↝, 1, Dose↝, 2, eff↑, 8, Half-Life↑, 1,
Clinical Biomarkers ⓘ
BG↓, 1, BP↓, 1, creat↓, 1, GutMicro↑, 1, IL6↓, 2, LDH↓, 1,
Functional Outcomes ⓘ
AntiDiabetic↑, 1, cardioP↑, 3, cognitive↑, 3, hepatoP↑, 2, memory↑, 2, motorD↑, 1, neuroP↑, 5, OS↑, 7, RenoP↑, 1, Strength↑, 1,
Total Targets: 64
Scientific Paper Hit Count for: OS, overall survival
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:36 Cells:% prod#:% Target#:229 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page